Edition:
United States

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.43USD
25 May 2018
Change (% chg)

$0.06 (+2.53%)
Prev Close
$2.37
Open
$2.32
Day's High
$2.43
Day's Low
$2.32
Volume
9,990
Avg. Vol
15,820
52-wk High
$5.15
52-wk Low
$2.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 28.14 -1.566
FY 2017 Dec '17 41.54 -2.797
Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.62 32.94
P/E High - Last 5 Yrs. -- 41.30 47.16
P/E Low - Last 5 Yrs. -- 23.45 24.79
Beta 1.59 0.78 0.78
Price to Sales (TTM) 0.20 3.46 8.13
Price to Book (MRQ) -- 3.60 4.34
Price to Tangible Book (MRQ) -- 4.46 5.84
Price to Cash Flow (TTM) -- 19.56 22.00
% Owned Institutions 19.10 1.27 2.41

Dividends

  Company industry sector
Dividend Yield -- 1.78 1.65
Dividend Yield - 5 Year Avg -- 0.77 0.79
Dividend 5 Year Growth Rate -- 2.61 4.02
Payout Ratio(TTM) -- 16.60 17.43

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.39 3.90 5.00
Sales (TTM) vs TTM 1 Yr. Ago 4.59 10.48 12.76
Sales - 5 Yr. Growth Rate 18.96 7.42 8.13
EPS (MRQ) vs Qtr. 1 Yr. Ago 46.77 38.83 35.26
EPS (TTM) vs TTM 1 Yr. Ago 68.55 -- --
EPS - 5 Yr. Growth Rate -- 7.08 8.59
Capital Spending - 5 Yr. Growth Rate -70.25 8.08 8.63

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.82 2.55 2.53
Current Ratio (MRQ) 0.88 3.63 3.61
LT Debt to Equity (MRQ) -- 10.41 12.75
Total Debt to Equity (MRQ) -- 12.92 15.82
Interest Coverage (TTM) -2.77 40.79 35.70

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 69.85 55.27 54.92
Gross Margin - 5 Yr. Avg. 65.88 52.57 52.70
EBITD Margin (TTM) 18.66 -- --
EBITD - 5 Yr. Avg 2.82 18.48 15.95
Operating Margin (TTM) -21.31 14.53 0.17
Operating Margin - 5 Yr. Avg. -55.06 14.25 11.24
Pre-Tax Margin (TTM) -45.62 14.82 2.21
Pre-Tax Margin - 5 Yr. Avg. -72.09 14.54 11.46
Net Profit Margin (TTM) -46.01 11.22 -1.22
Net Profit Margin - 5 Yr. Avg. -68.15 10.82 7.75
Effective Tax Rate (TTM) -- 22.49 31.16
Effective Tax Rate - 5 Yr. Avg. -- 23.87 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 844,825 842,778,435 732,879,315
Net Income/Employee (TTM) -388,672 98,072,151 85,224,914
Receivable Turnover (TTM) 4.25 5.74 5.88
Inventory Turnover (TTM) 6.78 2.52 3.58
Asset Turnover (TTM) 0.66 0.88 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.33 10.61 10.13
Return on Assets - 5 Yr. Avg. -26.41 11.71 11.15
Return on Investment (TTM) -50.48 13.26 12.79
Return on Investment - 5 Yr. Avg. -36.65 15.15 14.43
Return on Equity (TTM) -- 14.99 14.67
Return on Equity - 5 Yr. Avg. -696.55 16.38 15.77
  1 Year 3 Year 5 Year
Sales % 3.70 6.26 18.96
EPS (TTM) % 66.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 19.10%
# of Holders: 42
Total Shares Held: 2,267,328
3 Mo. Net Change: 9,345
# New Positions: 10
# Closed Positions: 6
# Increased Positions: 17
# Reduced Positions: 11
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.